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Abstract
The aim of this study was to immunolocalise type VI 
collagen and perlecan and determine their interactive 
properties in the intervertebral disc (IVD). Confocal laser 
scanning microscopy co-localised perlecan with type VI 
collagen as pericellular components of IVD cells and 
translamellar cross-bridges in ovine and murine IVDs. 
These cross-bridges were significantly less abundant 
in the heparin sulphate deficient Hspg2 exon 3 null 
mouse IVD than in wild type. This association of type 
VI collagen with elastic components provides clues as to 
its roles in conveying elastic recoil properties to annular 
tissues. Perlecan and type VI collagen were highly 
interactive in plasmon resonance studies. Pericellular 
colocalisation of perlecan and type VI collagen provides 
matrix stabilisation and cell-matrix communication which 
allows IVD cells to perceive and respond to perturbations 
in their biomechanical microenvironment. Perlecan, at 
the cell surface, provides an adhesive interface between 
the cell and its surrounding extracellular matrix. Elastic 
microfibrillar structures regulate tensional connective 
tissue development and function. The 2010 Global Burden 
of Disease study examined 291 disorders and identified 
disc degeneration and associated low back pain as the 
leading global musculoskeletal disorder emphasising its 
massive socioeconomic impact and the need for more 
effective treatment strategies. A greater understanding of 
how the IVD achieves its unique biomechanical functional 
properties is of great importance in the development of 
such therapeutic measures.
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Introduction
The outermost region of the intervertebral disc (IVD), 
the annulus fibrosus (AF), contains collagenous lamellae 
which convey important tensile properties to the IVD 
(Cortes, 2014). Superior and inferior cartilaginous 
endplates, layers of hyaline-like cartilage at the interface 
of the IVD and vertebral body, and the annular lamellae 
enclose the central proteoglycan (aggrecan)-rich region 
of the IVD, the nucleus pulposus (NP) (Humzah and 
Soames, 1988; Shapiro, 2014). Aggrecan forms massive 
link-protein-stabilised ternary aggregate structures with 
hyaluronan (HA), which have impressive water imbibing 
and space-filling properties. Physical entrapment of 
these aggrecan macro-aggregates in the type II collagen 
meshwork of the NP, combined with their water imbibing 
properties, generates an internal hydrostatic pressure in 
the NP providing hydrodynamic weight bearing properties 
to the IVD. This entrapment process occurs both through 
physical containment by the random type II collagen 
meshwork of the NP and by interaction of the N-terminal 
G1 domain of aggrecan with HA and interaction of the 
C-type lectin domain of the C-terminus of aggrecan with 
a number of structural matrix proteins (Day et al., 2004; 
Feng et al., 2006; Olin et al., 2001). These interactions 
link the HA-aggrecan macroaggregates with collagenous 
networks to form an interactive mechanosensory network 
in the interstitial matrix which is linked to the pericellular 
matrix. Such networks are also stabilised by interactions 
with biglycan, decorin (Wiberg et al., 2003), matrilin-1,-3 
and COMP (Fresquet et al., 2010). Type VI collagen 
is a major component of the chondron surrounding 
chondrocytes in tensional and weight bearing connective 
tissues (Horikawa et al., 2004; Poole et al., 1992); perlecan 
also has a prominent pericellular distribution (Melrose et 
al., 2006; Smith et al., 2010; Smith et al., 2009). Type VI 
collagen microfibrils interact with Von Willebrand Factor 
A domain-related protein (WARP) in the pericellular 
matrix of chondrocytes (Hansen et al., 2012) and regulate 
pericellular matrix properties, chondrocyte swelling, and 
mechanotransduction in mouse articular cartilage (Zelenski 
et al., 2015).
 Perlecan and type VI collagen are also associated with 
elastic microfibrillar proteins in the IVD (Hayes et al., 
2014; Hayes et al., 2011a; Hayes et al., 2011b; Hayes et al., 
2013). Perlecan promotes the coacervation of tropoelastin 
in vitro (Hayes et al., 2011a). De novo deposition of 
elastin on a biochip in a quartz crystal microbalance 
study involved electrostatic interactions between the 
tropoelastin and the HS side chains of perlecan and with 
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the core protein and C-terminal region of tropoelastin 
(Hayes et al., 2011a). HS chains have been shown to 
regulate N- and C-terminal interactions in fibrillin-1 (Cain 
et al., 2008), which result in the retention of fibrillin-1 
microfibrils at the cell surface (Bax et al., 2007); this is 
aided by an Arg-Gly-Asp (RGD) sequence in fibrillin 
and an RGD sequence in perlecan domain III which are 
interactive with cell surface integrins (Bax et al., 2007; 
Jovanovic et al., 2007; McGowan et al., 2008; Midwood 
and Schwarzbauer, 2002). This facilitates the assembly 
of elastic microfibrils at the cell surface; fibrillin-1 is the 
major component of elastin microfibrils (Kielty et al., 
2005; Kielty et al., 2002b). Microfibrils are assembled by 
head to tail attachment of fibrillin-1 molecules and lateral 
associations of the microfibrils into multimeric assemblies 
to support the coacervation of tropoelastin (Hayes et al., 
2011a) within these structures (Kielty et al., 2002a; Kielty 
et al., 2002c). These fibrillar assemblies are large enough 
to be visualised by light microscopy while the monomeric 
microfibrils require electron microscopy for visualisation 
(Kielty et al., 2002a; Kielty et al., 2005; Kielty et al., 
2002b; Kielty et al., 2002c; Sherratt et al., 2003). Fibrillin 
microfibrils provide viscoelastic properties to tissues (Ritty 
et al., 2002), aid in the anchorage of cells in the matrix 
(Bax et al., 2007; Jovanovic et al., 2007; McGowan et al., 
2008; Midwood and Schwarzbauer, 2002) and equip cells 
with mechanosensation (Kielty et al., 2002a; Kielty et al., 
2005; Kielty et al., 2002b; Kielty et al., 2002c; Sherratt 
et al., 2003), important in tissue function and cellular 
responsiveness which regulates tissue homeostasis in 
health and disease (Hubmacher et al., 2006; Jordan et al., 
2006; Jovanovic et al., 2007; Kielty et al., 2002a; Kielty et 
al., 2002c; Ramirez et al., 2008; Ramirez and Dietz, 2007; 
Ramirez et al., 2007).
 HS and integrin-mediated interactions of fibrillin 
regulate microfibrillar assembly and cellular adhesion; 
αVβ3, α5β1 and αVβ6 integrins all interact with fibrillin-1 
displaying high (Kd 40 nM), moderate (Kd 450 nM) and 
low (Kd 11 M) binding affinities, respectively (Jovanovic 
et al., 2007). αVβ3 Integrin regulates microfibril assembly 
in periodontal ligament (Tsuruga et al., 2009), and along 
with α5β1 integrin the activation of human umbilical vein 
endothelial cells (Mariko et al., 2010) and lung fibroblasts 
(McGowan et al., 2008), mediating cell signalling, cellular 
proliferation and cytoskeletal reorganisation which 
regulates cell migration.
 Elastic microfibrils are found at strategic locations 
between adjacent lamellae and within translamellar cross-
bridges, which provide elastic recoil properties to the 
collagenous lamellae (Kielty et al., 2002a; Kielty et al., 
2005; Kielty et al., 2002b; Li et al., 2012; Midwood and 
Schwarzbauer, 2002; Yu, 2002; Yu et al., 2005; Yu et al., 
2015; Yu et al., 2007; Yu et al., 2002). Latent transforming 
growth factor β (LTGFβ) binding proteins-1, 2 (LTBPs 
1, 2) are also associated with fibrillin-1 in microfibrils. 
Besides their structural roles in the extracellular matrix 
(ECM), LTBPs are key regulators of mesenchymal cell 
function (Davis et al., 2014; Kan et al., 2015). LTBP-2 is 
the only member of the fibrillin superfamily which does not 
sequester TGF-β1 within tissues; however, it competes with 
LTBP-1 for the same binding sites on fibrillin-1 and thus it 
may modulate TGF-β1 deposition in tissues (Hirani et al., 
2007). LTBP-2 also competes with tropoelastin for binding 
to fibulin-5, negatively regulating elastogenesis (Sideek et 
al., 2014). LTBP-2 has multiple HS binding sites (Parsi et 
al., 2010) and colocalises with perlecan in the IVD (Hayes 
et al., 2014). LTBP-2 has a single high-affinity binding site 
for fibroblast growth factor 2 (FGF-2) and blocks FGF-2-
induced cell proliferation (Menz et al., 2015) countering 
the HS-mediated cell proliferative properties of perlecan 
with FGF-2 (Knox et al., 2002).
 No studies have so far demonstrated the relative 
distributions of type VI collagen and perlecan in the 
IVD or their interactive properties. The present study 
addressed this deficiency and demonstrated interactive 
properties between type VI collagen and perlecan expected 
to convey important functional properties to the IVD in 
ECM organisation and stabilisation, cell-matrix and cell-
cell communication, and regulation of tissue homeostasis.
Materials and Methods
Materials
Rat monoclonal anti-perlecan domain-IV (A7L6) (ab2501) 
and rabbit anti-type VI collagen (ab6588) polyclonal 
antibodies were obtained from Abcam through Sapphire 
Bioscience (Waterloo, NSW, Australia). A rabbit polyclonal 
antibody to perlecan (CCN-1) was produced in-house 
against purified human endothelial perlecan. Antibodies 
against heparan sulphate (HS) (clone F58-10E4) and 
heparinase (Hep) III generated HS stubs (clone F69-3G10), 
chondroitinase ABC and heparitinase III (EC 4.2.2.8) 
were purchased from Seikagaku Corp. (Tokyo, Japan). 
Monoclonal anti-chondroitin-sulphate (CS) (clone CS56) 
was from Sigma-Aldrich (St. Louis, MO, USA). Mouse 
monoclonal CS stub antibodies (MAb 2B6, MAb 3B3) 
were gifts from Prof. Bruce Caterson (Cardiff University, 
Cardiff, UK). Rabbit anti type VI collagen (RDI-600-
401-108) for Western blotting was from Fitzgerald 
Industries International (North Acton, MA, USA). Alexa 
594-conjugated donkey anti-rat and Alexa 488-conjugated 
goat anti-rat IgG secondary antibodies were obtained from 
Molecular Probes (Eugene, OR, USA). Purified clostridial 
collagenase (CLSPA) was obtained from Worthington 
Industries through ScimaR (Templestowe, Victoria, 
Australia).
Tissues
The sheep used in this study (n = 6) were pedigree Merino 
wethers (castrated males) aged 18 months. C57BL6 
Wild type and Hspg2 exon 3 null mice were obtained 
from our breeding colonies at the Kearns animal facility, 
Royal North Shore Hospital. Appropriate clearances were 
obtained from our institutional ACEC for the experiments 
described.
Histological processing of IVD tissues
IVD-vertebral body segments were fixed in 10 % neutral 
buffered formalin for 48 h then decalcified in 10 % formic 
acid, 5 % neutral buffered formalin (7-10 d). A central 
4-5 mm thick vertical mid-sagittal slab was cut and 
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dehydrated in graded alcohols and xylene and the specimen 
double embedded in celloidin-paraffin.
 Lumbar spinal segments of 3 week old C57BL6 Wild 
type and Hspg2 exon 3 null mice were fixed 24 h in 10 % 
neutral buffered formalin and decalcified in 10 % formic 
acid, 5 % neutral buffered formalin for 72 h and embedded 
in paraffin using standard histological procedures. Serial 
parasagittal longitudinal sections were cut at 4 µm for 
histological examinations.
Bright-field immunolocalisation of type VI collagen 
in murine IVDs
Sections were de-waxed in xylene, washed in Tris-buffered 
saline (TBS) and primary antibody (1/100 dilution), 
rabbit anti-type VI collagen, applied overnight at 4 °C 
using a Sequenza apparatus. The specimens were then 
blocked for 1 h in Dako non-protein block and horseradish 
peroxidase-conjugated goat anti-rabbit IgG secondary 
antibody (1/1000 dilution) was applied for 3 h at room 
temperature. After washing in TBS, diaminobenzidine 
was added for the colour development step for 30 min at 
room temperature. The slides were then counterstained 
with Harris’ haematoxylin, coverslipped, and examined by 
brightfield microscopy utilising a Leica DFC 480 digital 
photomicroscope.
Laser scanning confocal microscopy
Ovine IVD sections (7 µm) were de-waxed in xylene and 
rehydrated, digested with 0.4 U/mL chondroitinase ABC 
in 100 mM Tris acetate buffer (pH 6.8) for 1 h at 37 °C, 
then blocked with normal donkey serum (1:20 dilution) 
for 30 min at room temperature. An anti-perlecan rat mAb 
(A7L6; 1:50 dilution) was then incubated on the sections 
overnight at 4 °C. Sections were washed, and an Alexa-
594-conjugated donkey anti-rat second antibody (1:200 
dilution) was applied for 1 h at room temperature. After 
washing, sections were again blocked with normal goat 
serum (1:20 dilution) for 30 min at room temperature before 
incubation with a rabbit anti-type VI collagen polyclonal 
antibody (VIB; 1:500 dilution) for 3 h at room temperature. 
Sections were washed before application of an Alexa 
488-conjugated goat anti-rabbit (1:200 dilution) secondary 
antibody for 1 h at room temperature. After a final wash, 
sections were mounted under coverslips in Vectashield 
mountant containing DAPI (Vector Laboratories, 
Peterborough, UK). Fluorescently stained tissue sections 
were visualised using a Leica TCS SP2 AOBS laser 
scanning confocal microscope (Leica, Heidelberg, 
Germany) using ×40 and ×63 oil immersion objectives. To 
avoid spectral cross-talk between fluorochromes, samples 
were sequentially scanned using excitation and emission 
settings for sequential recordings of DAPI (Ex. max: 359; 
Em. max: 461), Alexa 488 (Ex. max: 488; Em max: 520) 
and Alexa 594 (Ex. max 594; Em max: 618). Z-stacks 
of 8-bit ‘optical sections’ (512 × 512 pixels) were taken 
through the full thickness of tissue sections at between 
0.4 and 0.6 µm increments. ‘Maximum Intensity’-type 
reconstructions were prepared from the image stacks using 
Leica Confocal Software (Leica, Heidelberg, Germany) or 
Voxx 2 (written by Jeffrey L. Clendenon (Clendenon et al., 
2002); http://www.nephrology.iupui.edu/imaging/voxx).
Colocalisation analysis
Alexa 488 and Alexa 594-labeled perlecan and type VI 
collagen immunolocalisations were compared in single 
confocal optical sections using algorithms (described 
below) that were either built into the Leica Confocal 
Software or freeware plug-ins for Image J public domain 
Java image processing (http://rsb.info.nih.gov/ij/).
Colocalisation overlays
Regions of red-green co-localisation were demonstrated 
using the ImageJ co-localisation highlighter plug-in 
(written by Pierre Bourdoncle, Institut Jacques Monod, 
Service Imagerie, Paris, France; http://rsb.info.nih.gov/
ij/plugins/co-localization.html). Two points in the image 
were considered co-localised if their respective voxel 
intensities (0-255) were higher than the threshold value 
(50.0) of their channels and if the ratio of their intensity 
was higher than the ratio setting value (50 %). Applying 
these criteria, regions of red-green co-localisation were 
highlighted using a white overlay mask superimposed 
upon the original RGB image.
Intensity profiles
Leica Confocal Software (Leica, Heidelberg, Germany) 
was used to compare voxel intensity profiles obtained 
from arbitrary line segments that were drawn across 
individual cells and their surrounding ECM for both 
red and green channels. The resultant plots were used to 
assess similarities in both the distribution and intensity of 
fluorescent staining of perlecan (red) and type VI collagen 
(green). For each plot the horizontal axis represents line 
distance in mm and the vertical axis voxel intensity (scale 
of 0-255).
3D contour profiles
3D contour plots of voxel intensity data (0-255) from both 
red and green channels were rendered spatially as height in 
a 3D contour plot using the Image J interactive 3D Surface 
Plot plug-in (written by Kai Uwe Barthel, htw-berlin.de, 
Internationale Medieninformatik, Berlin, Germany; http://
rsb.info.nih.gov/ij/plugins/surface-plot-3d.html).
Isolation of ovine IVD perlecan
Pooled IVDs (L1-L2 to L6-L7) of two ovine lumbar 
spines were dissected into AF and NP, and these tissues 
separately extracted with 4 M GuHCl, 50 mM Tris-HCl, 
pH 7.2 containing 10 mM EDTA, 10 mM benzamidine, 
5 mM N-ethylmaleimide and 50 mM 6-aminohexanoic 
acid (10 mL extraction buffer/g tissue wet weight) using 
end-over-end mixing for 48 h at 4 °C. The tissue residue 
was spun down and discarded, and the extracts equilibrated 
in 6 M urea, 50 mM Tris-HCl, pH 7.2 and clarified 
using a 0.22 µm membrane. The extracts (30 mL) were 
chromatographed on a Hiload 26/10 preparative column 
of Q-Sepharose using an AKTA explorer chromatography 
system eluting at a flow rate of 12 mL/h and 3 mL fractions 
were collected. The column was washed with 2 bed 
volumes of starting buffer (50 mM Tris-HCl, pH 7.2, 6 M 
urea, buffer A) till a steady baseline was achieved. Bound 
perlecan was eluted with a linear 0-2.0 M gradient of NaCl 
in buffer A over 7 bed volumes. Protein (A280 nm) and 
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sulphated glycosaminoglycan (GAG) were monitored in 
each fraction; an in-line conductivity meter monitored 
the progress of the gradient. Most of the GAG (aggrecan) 
eluted at 1-2 M NaCl and was discarded. The fractions 
eluting between 0.1-0.3 M NaCl (fractions 20-25) 
contained perlecan species identified by dot blotting; these 
fractions were pooled and concentrated over a 100 kDa 
membrane by centrifugal ultrafiltration. The perlecan 
pools from anion exchange were examined by Superose 6 
HR10/30 FPLC. The column was eluted at 15 mL/h with 
50 mM Tris-HCl, pH 7.2, 0.15 M NaCl, 0.5 mL fractions 
were collected, and protein was monitored by A280 nm. 
Fractions 14-17 were subsequently pooled as purified 
perlecan and used for the BIAcore plasmon resonance 
studies. SDS-PAGE and Western blotting verified the purity 
of the perlecan preparations.
Purification of native collagen VI from ovine cornea
Frozen ovine corneas in liquid nitrogen were freeze 
shattered to a fine powder by pulverisation in a stainless 
steel mortar and pestle and resuspended in 10 mL of 50 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1 % (v/v) 
Nonidet P-40, 0.1 % (w/v) CHAPS (NET buffer) containing 
1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride, 20 mM 
N-ethylmaleimide protease inhibitors. After incubation 
at 4 °C for 2 h, insoluble material was pelleted by 
centrifugation (15,000 ×g for 5 min) and the pellet was 
washed twice with NET buffer and twice with 50 mM Tris-
HCl, pH 7.5, 400 mM NaCl, 10 mM CaCl2 (collagenase 
buffer). The insoluble material was resuspended in 
collagenase buffer (10 mL) containing 2500 units of 
collagenase (CLSPA, Worthington Biochemical Corp., 
Lakewood, NJ, USA) and 1300 units of hyaluronidase 
per g of cornea, 1 mM 4-(2-aminoethyl) benzenesulfonyl 
fluoride, and 20 mM N-ethylmaleimide. The samples were 
digested for 20 h at room temperature, insoluble material 
was removed from the preparation by centrifugation 
(15000 ×g for 5 min), and the clarified extract stored at 
4 °C. One mL of collagenase-digested ovine cornea was 
loaded onto a Sepharose CL2B column (100 × 1.6 cm2) 
pre-equilibrated in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl 
and 5 mM EDTA, and eluted at a flow rate of 0.5 mL/min 
collecting 3.0 mL fractions on a Frac 100 fraction collector 
using an AKTA explorer chromatography system. Eluant 
fractions were monitored at 280 nm and by BCA protein 
analysis. The void volume peak fractions were examined 
by 3-8 % Tris acetate gradient SDS-PAGE and the gels 
stained with Coomassie R250 and blotted to nitrocellulose 
for Western and dot blotting to identify the type VI collagen 
containing fractions, which were pooled and concentrated 
by centrifugal diafiltration over a 10 kDa cut-off membrane 
and the buffer exchanged into phosphate-buffered saline 
(PBS). The protein values of concentrated samples were 
measured against bovine serum albumin (BSA) as standard 
and stored frozen (−20 °C).
Surface plasmon resonance
Surface plasmon resonance experiments were performed 
using BIAcore 2000 (BIAcore AB, Uppsala, Sweden) 
optical biosensor with research-grade gold sensor chips. 
Binding experiments between perlecan immobilised on the 
sensor chips and collagen type VI were conducted in PBS, 
pH 7.4, at 20 °C. Immunopurified perlecan from human 
coronary artery endothelial cells (HCAEC) and perlecan 
purified from IVD was diluted in PBS to 20 µg/mL and 
coupled to gold sensor chips at a flow rate of 5 µL/min. A 
similar amount of each purified perlecan was immobilised 
to the gold chips in each case as determined from the 
change in response units. BSA (0.1 w/v %) in PBS (5 µL/
min) was exposed to the surface for 20 min to block non-
specific binding sites before rinsing with PBS at a flow 
rate of 20 µL/min for 10 min. Collagen type VI (20 µg/
mL) was then exposed to the sensor surface at a flow rate 
of 20 µL/min for 5 min. The experiments were repeated 
with immunopurified perlecan treated with Hep III and 
IVD perlecan treated with both chondroitinase ABC and 
Hep III. Sensograms were analysed using BIAcore 2000 
evaluation software 3.0. Binding experiments between 
perlecan immobilised on the sensor chips and collagen 
type VI were also conducted in the presence of perlecan 
peptides. Immunopurified endothelial perlecan treated with 
Heparinase III was coupled to gold sensor chips at a flow 
rate of 5 µL/min. Bovine serum albumin (0.1 w/v %) in 
PBS (5 µL/min) was exposed to the surface for 20 min to 
block nonspecific binding sites before rinsing with PBS 
at a flow rate of 20 µL/min for 10 min. Collagen type 
VI (20 µg/mL) was pre-mixed with one of the perlecan 
peptides (10 µg/mL) for 10 min prior to exposure to the 
immobilised perlecan at a flow rate of 20 µL/min for 5 min. 
The experiments were repeated using collagen type VI pre-
mixed with perlecan antibodies (5 µg/mL) instead of the 
peptides. Antibodies to perlecan domain I (A76), domain-
III (7B5) and domain-IV (A7L6) were used.
Endoglycosidase digestion
Samples were digested with 50 mU/mL proteinase free 
chondroitinase ABC in 0.1 M Tris acetate, pH 8, at 37 °C 
for 16 h to determine the presence of CS. Samples were 
also digested with 50 mU/mL Hep III in 10 mM Tris-HCl, 
pH 7.4, at 37 °C for 16 h to establish the presence of HS.
Western blotting
Purified perlecan samples (10 μg/lane) were treated 
with heparinase III (0.01 U/mL) or chondroitinase ABC 
(0.05 U/mL) in Dulbecco’s phosphate-buffered saline 
(DPBS), pH 7.2, at 37 °C for 16 h, and electrophoresed 
through 3-8 % Tris-Acetate NuPAGE® SDS-PAGE gels 
(Invitrogen, Carlsbad, CA, USA) for 1 h at 200 V in Tris-
Tricine buffer (50 mM Tricine, 50 mM Tris base, 0.1 % 
w/v SDS, pH 8.3). Molecular weight standards (HiMark®, 
Invitrogen) were also electrophoresed on each gel. Samples 
were then transferred to polyvinylidene difluoride (PVDF) 
membrane (Immobilon-P, Millipore, Billerica, MA, USA) 
using transfer buffer (5 mM Bicine, 5 mM Bis Tris, 0.2 mM 
EDTA, 0.005 % SDS, 10 % v/v methanol, pH 7.2) in a 
semi-dry blotter at 300 mA and 20 V for 1 h. The membrane 
was blocked with 1 % w/v BSA in TBS for 2 h at room 
temperature, followed by incubation with rabbit pAb CCN-
1 to perlecan diluted 1:10,000 in 1 % w/v BSA-TBS for 
16 h at room temperature. Membranes were subsequently 
rinsed with TBS, incubated with horseradish peroxidase 
(HRP)-conjugated goat anti-rabbit IgG antibodies 
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(1:50,000) for 45 min at room temperature, and rinsed in 
TBS before being imaged using chemiluminescent reagents 
(Femto reagent kit, Pierce Biotechnology, Rockford, IL, 
USA) and X-ray film (Australian Imaging Distributors, 
North Ryde, NSW, Australia).
Results
Dual fluorescent confocal immunolocalisations of perlecan 
and type VI collagen in IVD tissue sections demonstrated 
their discrete colocalisation in the pericellular matrix 
immediately adjacent to the disc cell margins in the outer 
(Fig. 1a-e) and inner AF (Fig. 1f-l) and NP (Fig. 2a-k). 
Type VI collagen had a more extensive distribution pattern 
extending further from the cell margins to the edge of the 
chondron surrounding the disc cells (Fig. 2g), whereas 
perlecan was more closely associated with the cell margins 
(Fig. 2f). Type VI collagen also linked strings of cells in the 
outer AF located along the major axis of the type I collagen 
fibre bundles laid down in the annular lamellae (Fig. 1b). 
This was also evident to a lesser extent around the cells 
of the inner AF (Fig. 1g), however in the NP cells type VI 
collagen and perlecan were discretely colocalised to the 
pericellular matrices around the margins of individual cells 
(Fig. 2h, k). Overlays of the co-localised areas of perlecan 
and type VI collagen immunolocalisation were calculated 
using Voxel 2 software to clearly demonstrate the areas of 
co-localisation (Fig. 1d, Fig. 1i, Fig. 2d, Fig. 2i), and image 
intensity profiles measured across cells of interest in a given 
field of view to further confirm the distributions of the 
fluorescent labels for perlecan and type VI collagen around 
selected cells of interest (Fig. 1e, Fig. 1j-l, Fig. 2e, j). Three 
dimensional intensity plots were also determined for a 
selected NP cell (Fig. 2k) from the perlecan and type VI 
collagen immunolocalisations (Fig. 2f, g), co-localisation 
(Fig. 2h) and voxel overlay image data (Fig. 2i). This 
clearly delineated areas of colocalisation, and confirmed 
the calculated image intensity profiles (Fig. 2e, f).
 Primary ovine IVD cells were grown in short term 
monolayer culture for 4 d to examine the perlecan they 
synthesised. Perlecan was laid down as a fine fibrillar 
network, this attached the cells to the tissue culture plastic 
and networked the disc cells (Fig. 3a, g). This network 
was substituted with HS identified by MAb 3G10 to the 
HS stubs (Fig. 3e, k) and with MAb 10E4 to native HS 
(Fig. 3f, l). Fibronectin (Fig. 4c, i) and laminin (Fig. 3d, j) 
were also detected pericellularly, but their deposition was 
Fig. 1. Dual localisation of perlecan (MAb A7L6) (a) and type VI collagen (b) around outer annulus fibrosus cells 
(a-e) and inner annulus fibrosus cells (f-l) by fluorescent confocal microscopy using Alexa 594 and 488 labelled 
secondary antibodies for visualisation. The perlecan-type VI collagen colocalisations are also presented as merged 
images (c,h) to demonstrate co-localisation and voxel overlays used to define co-localised regions (d,i). Image intensity 
plots through selected cells are also presented to demonstrate the localisation of perlecan and type VI collagen (e, 
j-l). Scale bars indicated in µm.
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Fig. 2. Dual localisation of perlecan (MAb 
A7L6) (a,f) and type VI collagen (b,g) around 
nucleus pulposus cells by fluorescent confocal 
microscopy using Alexa 594 and 488 labelled 
secondary antibodies for visualisation. The 
perlecan-type VI collagen colocalisations 
are also presented as merged images (c,h) to 
demonstrate co-localisation and voxel overlays 
used to define co-localised regions (d,i). Image 
intensity plots through a selected cell are also 
presented to demonstrate the localisation of 
perlecan and type VI collagen (e,j) and a 3D 
intensity plot through the x, y and z axes (k). 
Scale bars indicated in µm.
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Fig. 3. Comparative immunolocalisation of perlecan (a,g,m,o), fibronectin (c,i), laminin (d,j), MAb 3G10 ΔHS unsaturated 
stub epitope (e,k), native HS (f,l) and smooth muscle cell α-actin (n,p) synthesised by 4 d primary monolayer cultures 
of AF (a-f,m,n) and NP cells (g-l,o,p). Perlecan localisation was undertaken using anti domain-I perlecan antibody 
A76 (a,g,m,o), fibronectin using a pan-fibronectin Ab (c,i), laminin using a pan-laminin Ab (d,j). Plates (e) and (k) 
were predigested with heparitinase III to generate the ΔHS stub epitopes identified by MAb 3G10, while in plates (f) 
and (l) no predigestion was used with MAb 10E4 to native HS. The boxed areas in (a) and (g) are displayed at higher 
magnification in plates (m) and (o). Actin stress fibre formation by the AF and NP cells grown in monolayer culture 
are visualised in plates (n) and (p), respectively. Cell nuclei were counterstained with haematoxylin. All scale bars 
are 50 µm. Diaminobenzidine was used as chromogen in plates (a,g,m,o) and Nova RED was used in all other plates. 
Negative control plates for the AF and NP cultures are presented in (b) and (h), respectively.
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Fig. 4. (a) Isolation of type VI collagen tetramers from corneal extracts as collagenase resistant macromolecular material 
voiding a Sepharose CL2B column. SDS-PAGE of an aliquot of pooled fractions 26-30 stained with Coomassie R250 
(inset) and confirmation of type VI collagen in eluant fractions by dot blotting. Fractions 26-30 were subsequently pooled 
from four runs as a source of purified type VI collagen for use in Biacore plasmon resonance studies. (b) Isolation of 
perlecan from extracts of AF and NP tissue by DEAE Sepharose anion exchange chromatography employing gradient 
elution. The insets in (b) represent perlecan identified by Western and dot blots of individual fractions using pAb CCN-1. 
Under the elution conditions employed, fractions 20-26 contained the perlecan samples of interest, which were pooled 
and concentrated prior to examination by Superose 6 size exclusion FPLC. (c) Superose 6 FPLC of the perlecan anion 
exchange pool. The barred area represents the perlecan sample subsequently used for Biacore plasmon resonance 
studies. Elution fraction numbers are indicated with small arrows at the top of the figure as are the elution positions of 
blue dextran 2000 which was used to indicate the void volume (Vo) of the column and large molecular weight protein 
standards, thyroglobulin, bovine thyroid (669 kDa), ferritin, horse spleen (440 kDa), catalase, bovine liver (232 kDa), 
aldolase, rabbit muscle (158 kDa), transferrin (75 kDa), and ovalbumin, chicken (44 kDa). (d) Western blotting of GuHCl 
extracted AF and NP perlecan samples (lanes 1, 2), anion exchange AF and NP chromatography pools (lanes 4, 5), and 
Superose 6 pools (lanes 6, 7). A sample of affinity purified human umbilical vein endothelial cell perlecan (HUVEC, 
lane 3) is also shown. Prestained molecular weight standards (Novex see blue 2) are indicated in the Std lane. Lanes 
8-12 depict 3-8 % gradient SDS-PAGE of Superose 6 FPLC pools of the AF and NP perlecan samples (lanes 8, 9, 11, 
12) and purified type VI collagen (lane 10) visualised by Western blotting using anti perlecan domain IV (MAb A7L6) 
(lanes 8, 9) and anti-type VI collagen antibody (lanes 10-12) demonstrating a lack of type VI collagen reactivity in the 
purified perlecan samples (lanes 11, 12).
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Fig. 5. Plasmon resonance studies of the interaction of the HCAEC and disc perlecan and corneal type VI collagen. 
Information on peptides derived from perlecan domains II, III, IV and V which were used as competitive substrates in 
the type VI collagen-perlecan interactions is provided in (a). Interaction of ovine IVD perlecan (b) and HCAEC perlecan 
(c) with type VI collagen, and competitive binding of selected perlecan peptide fractions (d) and antibodies to perlecan 
domain I and III (e). The peptides were pre-incubated with type VI collagen before applying the mixture to immobilised 
HCAEC perlecan (pre-digested with heparanase III) on a chip. Peptides 2, 3 and 4 from domains III and IV of perlecan 
were more inhibitory than peptides 1 and 5. The results indicate that the HS chains in domain I of perlecan inhibit the 
interaction of collagen VI-perlecan. This interaction is instantaneous and involves multiple interactive binding sites 
along the perlecan core protein in all its five domains.
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Fig. 6. Demonstration of type VI collagen as a component of translamellar cross-bridge networks in 1 year old toluidine 
blue stained, Nomarski imaged and type VI collagen immunolocalised ovine (a-c) and 3 week old murine IVDs (d-k). 
A cross-section of a murine aorta (n,o) was used as a positive control tissue for the Van Geissen elastic stain, the boxed 
area in (n) is presented at higher magnification in (o) where five elastic lamellae are clearly evident in the intima. Van 
Geisen elastic stain visualises elastic structures in translamellar cross-bridges in C57BL/6 wild type (WT) (j) and 
Hspg2 exon 3 null HS deficient murine AF (k) using Nomarski DIC imaging and is consistent with the type VI collagen 
immunolocalisations in vertical sections of WT (d) and Hspg2 exon 3 null HS deficient murine AF (e). Translamellar 
cross-bridges visualised by toluidine blue depict proteoglycan deposition in these structures, ovine AF (a) and murine 
AF (f,g,h,i). Nomarski DIC imaged ovine cross-bridge (b). The number of annular lamellae (l) and translamellar cross-
bridges (m) were counted by morphometric image analysis of WT and Hspg2 exon 3 null mouse IVDs and quantified 
by 2 blinded observers using a scoring scheme established for murine IVD histopathology. Lamellae numbers were 
similar for both genotypes (l). WT mice had significantly more annular cross-bridges than the Hspg2 exon 3 null mice 
(p < 0.05) in the L2-L3, L3-L4 and L4-L5 IVDs. Box plots showing median, upper and lower quartile (box), 10-90th 
percentile (whiskers), and maximum and minimum values of the translamellar cross-bridge numbers and number of 
lamellae in murine IVDs. Differences between groups were assessed using nonparametric analysis (Mann-Whitney U 
test), p < 0.05 considered significant. Scale bars shown are 100 µm.
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Fig. 7. Immunolocalisation of type VI collagen to translamellar cross-bridges in newborn (a), 2 year (b), 4 year (c) and 
6 year old (d) ovine intervertebral discs; chromogen NovaRED. Ovine pancreas positive control (e). Scale bars 50 µm 
(a-e). Quantitation of the annular cross-bridge numbers in L2-L3 to L5-L6 IVDs in 5 sheep per age group (f). Cross-
bridge numbers were significantly lower in the newborn sheep group compared to the other sheep groups (p < 0.0001). 
Spinal level dependant trends in cross-bridge numbers were also evident with the L2-L3 IVDs having higher numbers 
and the L5-L6 IVDs the lowest in the 2-6 year old sheep groups; however, these values were only significant in the 
L4-L5 and L5-L6 IVDs of the 6 year sheep group which were higher than all other L4-L5 and L5-L6 IVDs examined 
(p < 0.05). Box plots showing median, upper and lower quartile (box), 10-90th percentile (whiskers), and maximum 
and minimum values of the translamellar cross-bridge numbers and number of lamellae in newborn, 2 and 6 year-old 
sheep IVDs. Differences between groups were assessed using nonparametric analysis (Mann−Whitney U test), p < 0.05 
considered significant.
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not as extensive as perlecan. Higher power images clearly 
showed the fine perlecan positive fibrillar material in the 
pericellular matrix of the AF (Fig. 3m) and NP cells (Fig. 
3o). The AF and NP cells elaborated an extensive actin 
cytoskeleton consistent with their elongation in culture 
(Fig. 3n, p).
 Corneal type VI collagen was isolated from ovine 
corneas using collagenase digestion and the tissue extract 
separated on a column of Sepharose CL2B (Fig. 4a). Dot 
blotting of aliquots of individual fractions confirmed the 
distribution of the type VI collagen peak that eluted in the 
void volume fractions. Further analysis of these pooled 
fractions by Western blotting using specific antibodies 
to type VI collagen and protein staining (Fig. 3a, inset) 
confirmed the identity and purity of the type VI collagen 
so isolated. Ovine intervertebral disc perlecan was isolated 
by 4 M GuHCl extraction from the tissue, equilibration 
of the extract in DEAE anion exchange buffer (6 M urea 
50 mM Tris-HCl, pH 7.2, 0.1 M NaCl), and separation 
of the extract by anion exchange chromatography on 
DEAE Sepharose employing gradient elution (0.1-2 M 
NaCl in starting buffer) (Fig. 4b). Perlecan eluted early in 
the NaCl gradient at ~0.25 M NaCl, well separated from 
aggrecan and versican, the major disc proteoglycans which 
eluted at ~0.8-1.5 M NaCl. Western blotting of individual 
fractions using perlecan-specific antibodies (MAb A7L6) 
subsequently identified perlecan eluting in fractions 20-28 
under the conditions we employed (Fig. 4b, inset). Samples 
of the DEAE perlecan pools were subsequently examined 
by Superose 6 size exclusion chromatography (Fig. 4c). 
Fractions eluting in the void volume were examined by 
SDS-PAGE and protein staining (Fig. 4d, lanes 8 and 9) 
and Western blotting to be full-length perlecan of high 
purity (Fig. 4d, lanes 6 and 7). The perlecan preparations 
did not cross-react with antibodies to type VI collagen 
(Fig. 3d, lanes 11 and 12). The purity of the corneal type 
VI collagen preparation isolated was also confirmed by 
Western blotting (Fig. 4d, lane 10).
 BIAcore surface plasmon resonance was conducted 
on full-length perlecan, perlecan fragments and type VI 
collagen (Fig. 5a, b). This demonstrated rapid interaction 
between these components in vitro, but only after prior 
removal of HS chains using pre-digestion with heparitinase 
III (Fig. 5c). The HS chains on human HCAEC perlecan 
inhibited the interaction with type VI collagen (Fig. 5c), but 
this was not apparent with the purified disc perlecan that 
contained no detectable HS or CS (Fig. 5b). Competitive 
binding fragments of perlecan from domains II, III, IV or 
V inhibited the interaction of full-length perlecan with type 
VI collagen to variable degree (Fig. 5d), as did specific 
antibodies to perlecan domain I (MAb A71) or domain III 
(MAb 7B5) (Fig. 5e). This indicated that the interaction 
between perlecan and type VI collagen had a rapid multi-
point attachment mechanism involving many regions of the 
perlecan core protein. IVD perlecan bound collagen type 
VI to a similar extent in both its untreated state and after 
treatment with endoglycosidases, but displayed ~50 % of 
the response compared to HCAEC perlecan (Fig. 5b). The 
interaction between HCAEC perlecan and collagen type 
VI was inhibited by the presence of HS (Fig. 5c). HCAEC 
perlecan that had been treated with heparanase III bound 
twice as much type VI collagen as IVD perlecan, even 
though the same amount of perlecan was coated on the 
BIAcore chip. The association rate of collagen type VI 
to each perlecan was similar with equilibrium achieved 
instantaneously. The dissociation rate was marginally 
slower for collagen type VI on heparanase III-predigested 
HCAEC perlecan than any of the other test conditions. 
Thus the binding characteristics of collagen type VI to 
endothelial and IVD perlecan differed. Binding was only 
conducted at one concentration thus it was not possible to 
calculate binding constants.
 A histological examination of the role of type VI 
collagen in the structural organisation of the IVD 
indicated that besides being a prominent pericellular 
matrix component, type VI collagen was also a prominent 
component of the translamellar cross bridging networks 
in ovine (Fig. 6a-c) and murine IVDs (Fig. 6d-k). The 
appearance of these bridges differed between the ovine 
and murine IVDs; proteoglycan was a more predominant 
component of the ovine cross bridges (Fig. 6a) and these 
could also be visualised using Nomarski optics (Fig. 
6b) and readily detected immunohistochemically using 
antibodies to type VI collagen (Fig. 6c, d, e). The annular 
cross bridges were less prominent in the Hspg2 exon 3 
null mice (Fig. 6g, i). The van Geissen elastic stain was 
particularly useful for the delineation of the cross bridges in 
the murine IVDs, which presumably reflects their relative 
content of elastic fibre components (Fig. 6d, e). The murine 
aorta was a useful positive control tissue for the elastic van 
Geissen stain, with the elastic layers clearly defined by this 
staining procedure (Fig. 6n, o). The numbers of annular 
lamellae and annular cross bridges were manually counted 
in mid-sagittal longitudinal lumbar spinal sections in the 
C57BL6 wild type and Hspg2 exon null mice (Fig. 6l, 
m). The number of annular lamellae did not vary between 
the two genotypes, however the number of cross-bridges 
showed a decreasing trend towards the L5-L6 IVD in the 
wild type but not the Hspg2 null mouse IVDs (Fig. 6l, 
m) and this was statistically significant (p < 0.05). Closer 
inspection of the translamellar cross-bridges in the lumbar 
ovine IVDs also showed age and spinal level dependant 
trends in their abundance (Fig. 7a-d, f). The relative size 
of the cross-bridges decreased significantly with advancing 
age, which was clearly evident in immunolocalisations 
conducted with an anti-type VI collagen antibody (Fig. 
7a-d). The numbers of cross-bridges decreased in number 
in the lumbar spinal segments, with a significant decrease 
in the 2-6 year old IVDs at comparable spinal levels to the 
newborn sheep IVDs (Fig. 7f). There was also a decreasing 
trend in cross-bridge numbers when progressing down the 
spine to the lower lumbar IVDs (L5-L6), with the L5-L6 
IVD having the lowest numbers of cross-bridges at all 
age points of the IVDs examined (Fig. 7f). The relative 
numbers of cross-bridges were significantly higher in the 
murine IVDs compared to the ovine lumbar IVDs, with 
average numbers ranging from 30-80 in the murine wild 
type IVDs compared to 18-75 in the ovine IVDs. Thus the 
density of the cross-bridges was significantly higher in the 
murine IVDs and similar to the relative cell densities in 
these tissues.
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Discussion
A number of publications have shown that pericellular 
matrix components have biomechanical functions in 
tensional and weight bearing connective tissues (Cao et 
al., 2007; Cao et al., 2009; Cao et al., 2011; Darling et 
al., 2010; Guilak et al., 2006; McLeod et al., 2013; Wilusz 
et al., 2012). Evidence from theoretical modelling and 
experimental studies shows that the pericellular matrix 
receives biomechanical signals that regulate cellular 
metabolism in tensional and weight bearing connective 
tissues. The present study has shown type VI collagen 
is a major component of the chondron (Horikawa et al., 
2004; Poole et al., 1992) as is perlecan (Melrose et al., 
2006); however, no comparative studies have specifically 
demonstrated their specific distributions within the disc cell 
chondron. Type VI collagen was present in an extended 
region extending away from the cell to the margins of 
the chondron interconnecting rows of cells aligned along 
the collagen fibre bundles in the outer AF and to a lesser 
extent in the inner AF, but was not observed in the NP 
where it formed a discrete pericellular matrix around 
individual NP cells. In articular cartilage, atomic force 
microscopy shows that pericellular localisation of perlecan 
provides compliancy to the type VI collagen lattices 
encompassing the chondrocyte (Wilusz et al., 2012). 
Type VI collagen is a transducer of biomechanical and/
or biochemical signals originating in the ECM (Guilak et 
al., 2006) via coupled interactive networks between the 
pericellular matrix and link protein-stabilised aggrecan-
HA or versican-HA networks (Day et al., 2004; Feng et 
al., 2006; Fresquet et al., 2010; Olin et al., 2001; Wiberg 
et al., 2003). The contributions type VI collagen makes 
to tissue function is obvious in type VI collagen knock-
out mice, where knee and hip articular cartilage develop 
osteoarthritis (OA) (Doane et al., 1998) and tendons have 
diminished biomechanical capability. Type VI collagen 
has binding sites for integrins which connect the cell to 
its biomechanical microenvironment (Burg et al., 1996) 
including α1β1, α2β1, α10β1 and α11β1; disc cells express 
α1β1 integrin and α1, α2, α5, αV, β1, β3 and β5 subunits 
(Burg et al., 1996). Pericellular CSPG4, a 250 kDa 
proteoglycan, is considered a type VI collagen receptor 
(Burg et al., 1996; Doane et al., 1998; Nishiyama and 
Stallcup, 1993; Stallcup et al., 1990; Tillet et al., 2002).
 In monolayer cultures of disc cells, the pericellular 
matrix contained fine fibrillar perlecan positive material; 
fibronectin and laminin deposition was less extensive. The 
disc cells also displayed an extensive actin cytoskeleton 
facilitating cellular extension and cell spreading. Perlecan is 
interactive with cell adhesive proteins, cell surface integrins 
and structural ECM glycoproteins (Whitelock et al., 2008) 
providing cell-matrix and cell-cell interconnections. Type 
VI collagen also interacts with cell surface integrins 
facilitating cell-matrix interconnection and communication 
(Horikawa et al., 2004; Tulla et al., 2001; Zelenski et al., 
2015). In the present study, interaction between perlecan 
and type VI collagen using surface plasmon resonance 
demonstrated rapid multi-point interactions involving all 
five domains of perlecan. LTBP-2 also displays pericellular 
colocalisation with perlecan in IVD tissues (Hayes et al., 
2014) and contains a single high affinity FGF-2 binding 
site (Menz et al., 2015). Disulphated CS chains on growth 
plate perlecan direct collagen fibrillogenesis (Kvist et al., 
2006). Perlecan in the human foetal spine is substituted 
with HS (Shu et al., 2013b) and the 7D4 CS sulphation 
motif (Shu et al., 2013a), but with tissue maturation this 
epitope becomes virtually undetectable. Type VI collagen-
rich translamellar cross-bridges in the IVD interconnect 
up to 18 lamellar layers (Melrose et al., 2008; Schollum 
et al., 2010; Yu et al., 2015). The precise role of these 
translamellar cross-bridges is unclear; however, the 
interconnections they provide and presence of elastic 
components in the cross-bridges suggests a supportive 
role in disc tissues. The fact that cross-bridge numbers 
vary along the lumbar spine and with ageing indicates their 
assembly is responsive to intrinsic spinal biomechanical 
forces. The cross-bridges may provide resiliency to the 
collagenous lamellae. Collagen fibrils are inextensible 
and once loaded are incapable of returning to their pre-
stressed dimensions, thus the elastic components in the 
cross-bridges may provide recoil properties.
 The IVD provides mechanical stability during axial 
and torsional loading and spinal flexibility during flexion 
and extension and absorbs and dissipates spinal forces 
preventing these concentrating in the lower lumbar regions, 
an unfortunate consequence of the erect human posture. 
Supraphysiological loading of the IVD leads over time to 
the development of disc degeneration and the development 
of low back pain (LBP). As seen in the present study, 
the highly interactive properties of type VI collagen 
and perlecan provide matrix stabilisation. Perlecan also 
provides cohesive properties to the cell-ECM interface 
contributing to cell-matrix communication and the ability 
of the disc cell to perceive and respond to changes in its 
biomechanical microenvironment. Disc cells are exposed 
to a hostile environment of low oxygen tension, high lactic 
acid levels, low nutrition and a high hydrostatic pressure 
leading to cell death and a diminution in cell numbers over 
time due to cellular senescence (Vo et al., 2016; Wang et al., 
2016), apoptosis (Kermani et al., 2014; Kuo et al., 2014) 
and autophagy (Gruber et al., 2015; Ma et al., 2013). Thus, 
it is important that measures are in place to protect the disc 
cell and maintain the composition of IVD tissues. Type VI 
collagen and perlecan both form part of these protective 
measures. Even so, an age-dependant decline occurs in IVD 
cell numbers to such an extent that the remaining cells are 
incapable of adequately replenishing ECM components 
to maintain tissue homeostasis and optimal mechanical 
stability. The subsequent degenerative changes in the 
IVD, which ensue eventually, result in the generation of 
low back pain in ~40 % of degenerate IVDs. The Global 
Burden of Disease study of 2010 identified LBP as the 
number one global musculoskeletal condition (Hoy et al., 
2014a; Hoy et al., 2010; Hoy et al., 2014b; Maniadakis 
and Gray, 2000; Vos et al., 2012; Walker et al., 2003) with 
major socioeconomic impact. There is, therefore, a strong 
imperative for the development of effective treatment 
strategies for LBP. A greater understanding of how the 
IVD achieves its unique biomechanical properties is very 
useful background information in the development of such 
therapeutic measures.
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Conclusions
Perlecan and type VI collagen are important interactive 
components of the disc cell pericellular matrix; their 
diverse range of interactive partners and ability to form 
network structures between cell and matrix reinforce 
their importance in mechanosensory and cell regulatory 
functions which affect cellular survival and tissue 
homeostasis.
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Discussion with Reviewers
Reviewer I: Since collagen VI is ubiquitously expressed, is 
there evidence in other tissues that collagen VI is associated 
with elastic recoil properties in other tissues.
Authors: We believe these recoil properties are really 
a function of the elastin networks type VI collagen is 
attached to in the tissue, thus this probably occurs in any 
tissue containing these networks and type VI collagen. 
However, there are some surprising tissue locations where 
type VI occurs such as the hypertrophic cells of the ovine 
vertebral growth plate (Melrose et al., 2002; Melrose 
et al., 2016) and trabecular bone, and it remains to be 
determined if elastin networks are also important in these 
tissues. Although elastin is a relatively minor component 
of IVD tissues, elastin fibres are nevertheless prominent 
in the IVD running both within and between collagenous 
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lamellae of the AF and in specialised structures such as 
the translamellar cross bridge. In articular cartilage, elastin 
fibres occur as an interritorial network in the surface zone 
and pericellular matrix. An important question is why do 
elastin and type VI collagen fibrils occur so prominently 
in tissues containing dense collagenous fibrillar arrays 
which provide the predominant biomechanical character 
of that tissue, namely mechanical strength under tensional 
loading. Type VI collagen fibrils are also distributed in 
close proximity to these elastic and collagen fibrillar 
arrangements; however, they have not been ascribed a 
mechanical role similar to that of the fibrillar collagens. 
Rather, the type VI collagen networks appear to act as a 
linker of functional ECM components such as the collagen 
fibrillar assemblies, HA-aggrecan macromolecular arrays, 
and elastin networks. Thus an interplay exists between 
these components to provide IVD tissue with its ability to 
withstand tensional and compressional forces. Further, this 
extended type VI collagen-fibrillar collagen-HA-aggrecan-
elastin network provides a means of dissipating mechanical 
forces throughout the ECM, preventing focal overload of 
individual collagen fibrils or fibre bundles. Thus, a synergy 
exists between collagen fibrillar arrangements, elastin and 
type VI collagen in connective tissues. Various models 
have attempted to describe the interactive associations 
between these entities. Elastin fibres have been proposed 
to have roles during low tissue deformation, acting as a 
buffering component prior to recruitment of collagen fibres 
which resist tensional forces at high tissue deformation. 
These forces are dynamic, thus the elastin fibres are 
again recruited once the collagen fibres are unloaded and 
relaxed; however, they are relatively inextensible and the 
elastin fibrils return these to their original pre-stressed 
dimensions. Thus a recoil property can be envoked for the 
elastin-type VI collagen assemblies in the tissue. These 
interrelationships are deduced from electron microscopy 
and immunolocalisation data and functional biophysical 
studies on isolated macromolecular components. Direct 
evidence to support the roles of the isolated components 
at the fibrillar and microfibrillar level is incomplete, due to 
their small size and the complexity of the heterogeneous 
environment of the elastin microfibrils/fibrils. Atomic force 
microscopy is, however, providing invaluable information 
on the role of type VI collagen and perlecan in tissues, but 
these need to be considered in relation to the other ECM 
components they are attached to. Like elastin, collagen VI 
forms distinct microfibrillar ECM networks and anchors 
interstitial structures, such as nerves, blood vessels and 
larger collagen fibrils. Collagen VI also mediates cell-cell 
communication and matrix assembly. The von Willebrand 
domains of type VI collagen facilitate its interaction with 
cells and it is also interactive with a number of integrins 
and CSPG4. Blood vessels are subject to pulsatile forces, 
thus the type VI ECM experiences high shear due to blood 
flow followed by a relaxed state between heart beats. So it is 
likely that elastin-type VI collagen also provides resiliency 
to these and related tissues.
Reviewer II: Fig. 2 nicely shows distinct patterns of 
collagen VI and perlecan that are only partially co-
localised. Do the authors have any hypotheses on the 
relative interaction of these components with the cells, and 
whether the regional distribution provides any cues as to 
the function of these molecules in cell-matrix interactions?
Authors: Our original title to the paper suggested roles 
for type VI collagen and perlecan in matrix assembly, 
mechanotransduction and cell-ECM signalling. The title 
has been amended in the revised manuscript; however, 
these remain as areas where we believe type VI collagen 
and perlecan have important roles to play. Many studies 
have demonstrated the ECM and pericellular matrix 
components with which perlecan can interact. Perlecan also 
interacts with α5β1 and α2β1 integrin. The latter involves 
the endorepellin domain of perlecan which has anti-
angiogenic properties when released from the core protein. 
These interactions anchor the cell within the ECM and 
equip it with mechanoresponsiveness through perlecan-
type VI collagen networks with other ECM components. 
Type VI collagen acts as a linker network between the 
pericellular matrix and collagen-HA-aggrecan-elastin 
networks in the interstitial matrix providing an extended 
remote sensory system for mechanotransductive feedback 
effects facilitating cell-matrix communication and 
appropriate responses by the cell which maintain tissue 
homeostasis.
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